By considering the high frequency of p53 mutations in HPV-negative HNSCC and the hypoxia observed in these tumours, the co-operation between p53 mutants and HIF-1 signalling might represent a meaningful avenue for clinical investigation. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.